40 results
Page 2 of 2
10-K
EX-10.21
886hi
1 Mar 21
Annual report
12:00am
10-K
o8g2494 m6
1 Mar 21
Annual report
12:00am
6-K
EX-99.1
odx9r9y8y4ae9buliisl
29 Dec 20
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List
7:30am
6-K
EX-1.1
0u4us
21 Sep 20
Current report (foreign)
4:15pm
6-K
EX-99.1
ttk6nhlus2f vhifpnsk
11 Sep 20
Zai Lab Limited Supplemental and Updated Disclosures
8:09am
424B2
tnrogeyf53 noss47
24 Jan 20
Prospectus for primary offering
7:24am
6-K
EX-1.1
umix5xu688rohumrz
22 Jan 20
Current report (foreign)
11:58am
424B5
0qrpvqp8f9hs
21 Jan 20
Prospectus supplement for primary offering
5:31pm
20-F/A
EX-10.15
eqc65t5
23 Aug 19
Annual report (foreign) (amended)
5:00pm
20-F/A
EX-10.15
zk9dwz32v81z
26 Jun 19
Annual report (foreign) (amended)
6:07am
6-K
EX-1.1
7y1nthxw 54c6q12cc3
2 May 19
Current report (foreign)
11:39am
6-K
EX-99.1
sfcldgc 8j4un175t0z
12 Dec 18
Zai Lab Announces Acceptance of NDA Submission of ZEJULA (Niraparib) in Mainland China by the NMPA
7:35am
424B4
a12haivbth0b8eyn8xq
7 Sep 18
Prospectus supplement with pricing info
12:00am
20-F
pm8dy9 xdgway
30 Apr 18
Annual report (foreign)
9:07am
20-F
EX-4.11
tdrs3a
30 Apr 18
Annual report (foreign)
9:07am